Author

Edgar Villena-Macia

Servicio de Salud de Castilla La Mancha

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Eva María Galán‐MoyaiD· 1 shared Fernando Andrés PreteliD· 1 shared Maissaa Bouchakour-Bouchaqor· 1 shared Paula Sánchez‐Olivares· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

4 top collaborators · 6 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Eva María Galán‐MoyaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

SIRT2, TFEB, CNIH3, ADRM1, AND TM9SF4 AS POTENTIAL BIOMARKERS OF RESISTANCE TO CRIZOTINIB AND POOR PROGNOSIS IN LUNG ADENOCARCINOMA: IMPLICATIONS FOR TARGETED THERAPY AND IMMUNOTHERAPY

Edgar Villena-Macia, Maissaa Bouchakour-Bouchaqor, Paula Sánchez‐Olivares, Fernando Andrés Pretel, Eva María Galán‐Moya

This study identifies five genes associated with crizotinib resistance and poor prognosis in lung adenocarcinoma, suggesting potential therapeutic targets and strategies.

bioRxiv · Jul 10, 2025 · PreprintCancer Biology